Published in Br J Haematol on October 01, 1991
Interferon lambda: a new sword in cancer immunotherapy. Clin Dev Immunol (2011) 1.04
Differential human multiple myeloma cell line responsiveness to interferon-alpha. Analysis of transcription factor activation and interleukin 6 receptor expression. J Clin Invest (1997) 0.83
Immunomodulatory effects of alpha interferon and thymostimulin in patients with neoplasias. Clin Diagn Lab Immunol (1995) 0.75
Anti-VEGFR2-interferon-α2 regulates the tumor microenvironment and exhibits potent antitumor efficacy against colorectal cancer. Oncoimmunology (2017) 0.75